Scholarlink

<p>To evaluate the efficacy of pre-incisional bupivacaine infiltration in reducing postoperative pain and enhancing recovery in pediatric patients undergoing tonsillectomy.The current randomized controlled study was conducted in a tertiary care hospital with 64 children aged 5–14 years undergoing cold steel tonsillectomy, randomly by dividing them into two equal groups (Group B and GroupN). Group B received 0.5% bupivacaine (2 mg/kg, maximum 3 mL) and Group N received 0.9% saline infiltrated into both peritonsillar regions pre-incisionally. Postoperative pain was assessed using the Faces Pain Scale-Revised (FPS-R) and Objective Pain Scale (OPS). Secondary outcomes included analgesic requirement, fossa healing, time to normal diet, sleep, activity and school resumption. Group B showed significantly lower pain scores than Group N most of the times on both FPS-R and OPS. It was found that analgesic requirement beyond postoperative day 3 was significantly less in Group B with earlier resumption of normal diet, physical activity, and school attendance while there was no significant difference observed in slough healing between groups. Pre-incisional bupivacaine infiltration significantly reduces postoperative pain and accelerates recovery in children post procedure, promoting earlier return to normal diet and daily activities.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of effect of pre-incisional infiltration of bupivacaine on postoperative pain outcome in patients undergoing tonsillectomy: a randomized control study

  • 期刊论文

  • 发表日期：

    2026年4月4日

查看全文
  • Shubham Bhatnagar,
  • Neha Salaria,
  • Naveen Sharma

摘要

To evaluate the efficacy of pre-incisional bupivacaine infiltration in reducing postoperative pain and enhancing recovery in pediatric patients undergoing tonsillectomy.The current randomized controlled study was conducted in a tertiary care hospital with 64 children aged 5–14 years undergoing cold steel tonsillectomy, randomly by dividing them into two equal groups (Group B and GroupN). Group B received 0.5% bupivacaine (2 mg/kg, maximum 3 mL) and Group N received 0.9% saline infiltrated into both peritonsillar regions pre-incisionally. Postoperative pain was assessed using the Faces Pain Scale-Revised (FPS-R) and Objective Pain Scale (OPS). Secondary outcomes included analgesic requirement, fossa healing, time to normal diet, sleep, activity and school resumption. Group B showed significantly lower pain scores than Group N most of the times on both FPS-R and OPS. It was found that analgesic requirement beyond postoperative day 3 was significantly less in Group B with earlier resumption of normal diet, physical activity, and school attendance while there was no significant difference observed in slough healing between groups. Pre-incisional bupivacaine infiltration significantly reduces postoperative pain and accelerates recovery in children post procedure, promoting earlier return to normal diet and daily activities.